blinatumomab
amgen
['nct02101853']
#asco23 #asco2023 by contrast, similar outcomes and poor dfs for both arms were observed in the one third of patients with iem; new treatment approaches are needed for these patients ( identifier: nct02101853).
Biomedical Science that Inspires. #medicine #medtwitter #meded #Science #Research #Technology #News